SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New CAR T-Cell Therapy Approved for Leukemia

2.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

3.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

4.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

5.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot